Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 66 entries
View as:

A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01402076 Org: User:
Start: 08/31/11 End: 08/31/11 Due: 08/31/12

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01428661 Org: User:
Start: 09/30/11 End: 05/31/13 Due: 05/31/14

Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients

Phase: N/A Priority: Normal
NCT ID: NCT01495169 Org: User:
Start: 10/31/11 End: 02/28/15 Due: 02/28/16

Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01163032 Org: User:
Start: 08/31/10 End: 11/30/12 Due: 11/30/13

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT06953869 Org: User:
Start: 04/21/25 End: 01/31/28 Due: 01/31/29

A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use

Phase: N/A Priority: Normal
NCT ID: NCT06804603 Org: User:
Start: 02/25/25 End: 07/06/25 Due: 07/06/26

Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)

Phase: N/A Priority: Normal
NCT ID: NCT04652882 Org: User:
Start: 12/09/20 End: 12/31/25 Due: 12/31/26

Open-Label Evaluation of Relapse Prevention in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT06961968 Org: User:
Start: 05/31/25 End: 11/30/27 Due: 11/30/28

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00254202 Org: User:
Start: 11/18/05 End: 03/21/07 Due: 03/21/08

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03838926 Org: User:
Start: 09/27/18 End: 09/30/20 Due: 09/30/21

Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception

Phase: N/A Priority: Normal
NCT ID: NCT01218789 Org: User:
Start: 10/28/10 End: 12/05/24 Due: 12/05/25

Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis

Phase: N/A Priority: Normal
NCT ID: NCT02970968 Org: User:
Start: 11/30/16 End: 12/31/18 Due: 12/31/19

VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness

Phase: N/A Priority: Normal
NCT ID: NCT00467441 Org: User:
Start: - End: - Due: -

Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety

Phase: N/A Priority: Normal
NCT ID: NCT04800237 Org: User:
Start: 02/23/21 End: 08/02/22 Due: 08/02/23

A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT06296966 Org: User:
Start: 02/29/24 End: 07/31/24 Due: 07/31/25

Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol

Phase: N/A Priority: Normal
NCT ID: NCT01578057 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01271387 Org: User:
Start: 01/31/11 End: 08/31/11 Due: 08/31/12

Patient Registry of Blind Subjects With Sleep-related Problems

Phase: N/A Priority: Normal
NCT ID: NCT01195558 Org: User:
Start: 04/30/10 End: 04/30/30 Due: 04/30/31

Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04969211 Org: User:
Start: 06/30/21 End: 10/13/21 Due: 10/13/22

Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies

Phase: N/A Priority: Normal
NCT ID: NCT04622345 Org: User:
Start: 11/21/20 End: 06/28/21 Due: 06/28/22

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00291187 Org: User:
Start: 02/28/06 End: 08/31/06 Due: 08/31/07

Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances

Phase: N/A Priority: Normal
NCT ID: NCT03154697 Org: User:
Start: 01/31/16 End: 12/31/30 Due: 12/31/31

Relapse Prevention Study in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01291511 Org: User:
Start: 02/28/11 End: 03/31/15 Due: 03/31/16

Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00490945 Org: User:
Start: 07/31/04 End: 03/31/05 Due: 03/31/06

Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)

Phase: N/A Priority: Normal
NCT ID: NCT02180451 Org: User:
Start: 06/30/14 End: 01/31/17 Due: 01/31/18